Figure 4From: Neoadjuvant or adjuvant therapy for resectable esophageal cancer: a systematic review and meta-analysis Meta-analysis examining preoperative and postoperative chemotherapy and surgery to surgery alone: mortality at one year. Overall risk ratio = 0.99 (95% CI, 0.81 to 1.21; p = 0.93)Back to article page